"Transient worsening...and, subsequently...very favorable responses". Very much like what happens with immune checkpoint inhibitors in melanoma. The FDA was so concerned about this response pattern that it approved ipilimumab.
"Transport the BBB" makes no sense. Try your scaremongering again, but this time in English.
Every time it looks like it's going to sustain a move upward, the bid is hit with a large number of shares and downward momentum is created. Today will be a fight just to stay green.
It's gradually trending downward on decreasing volume as the day goes on. Recent moves upward have been countered with sudden selling (shorting?).
The anti-tumor response may also be abrogated. Anti-CD27 administration may have to be intermittent, to prevent depletion of the precursor pool.
There was really no need for this to give back all of yesterday's gains, but it's unfortunately typical. SGEN continued to fall even at times the NASDAQ was improving.
I doubt you've ever done anything of meaning or value in your entire life. No one believes you're capable of anything you've claimed to have done with this stock.
And in a brutal market, with the NASDAQ tripping over itself to head lower. Good strength from CLDX.
Yep. Everyone seems to have forgotten the big jump on the news of the relatively trivial BMS collaboration. It sank quickly afterwards. Could be a similar trend here, as shares are dumped on high volume after a pop related to non-earth-shattering news..
While CLDX is far from a perfect company, it has been running trials which haven't taken 10+ years to complete and there is so far no evidence of uncomfortably close ties with companies linked to its CEO.
You've been a member of this board for a day or less and you've already sh4t out 25 low-quality posts. I'll give you a thumbs-down before I put you on ignore.
It's not that the news is good--it just isn't bad. There was no home run.
There's some talk that CLDX could file for approval based on these results. Great if that's true.